To Evaluate the Use of ASTHMA IQ in a Primary Care Setting (AIQ)

The study will recruit approximately 400 patients with chronic persistent asthma. The required sample size to identify a clinically significant difference in ACT scores from baseline and between groups requires about 200 patients per group.

Inclusion Criteria:

1. Male or female patients, age 12 through 65 years at the time of screening;
2. Written informed consent obtained from the patient prior to beginning study procedures;
3. Documented clinical history of chronic persistent asthma requiring controller therapy;
4. Able to complete the study period, including follow-up period, of up to approximately 2 years; and
5. Willing to forego other forms of experimental treatment and study procedures during the study and for 30 days after the follow-up period is completed.

Exclusion Criteria:

1. History of any disease, evidence of any current disease (other than asthma), any finding upon physical examination, or any laboratory abnormality, that, in the opinion of the investigator, may compromise the safety of the patient in the study or confound the analysis of the study;
2. Lung disease other than asthma (e.g., chronic obstructive pulmonary disease, cystic fibrosis);
3. Any disease or illness, other than asthma, that is likely to require the use of systemic corticosteroids during the study period;
4. Current acute illnesses or evidence of significant active infection, such as fever ≥ 38.0°C (100.5°F) within 4 weeks of enrollment;
5. Receipt of any investigational drug therapy within 30 days or any biologic(s) within 5 half-lives prior to screening, except omalizumab for asthma;
6. Pregnancy at enrollment;
7. Breastfeeding or lactating females;
8. Elective major surgery planned from screening through study completion;
9. History of cancer other than basal cell carcinoma of the skin or cervical carcinoma-in-situ treated with apparent success with curative therapy more than 1 year prior to enrollment;
10. History of primary immunodeficiency;
11. History within the past year of excessive alcohol intake or drug addiction.
12. History of tobacco use of more than 10 pack years;
13. Plans to move from the study site area during the duration of the study.

Other protocol-defined inclusion/exclusion criteria may apply